Continued co-circulation of multiple human parainfluenza virus type 3 lineages in Fukushima and Miyagi, Japan in 2025
Kazuya Shirato1, Miyuki Kawase1, Satoko Sugimoto1,2
1Department of Respiratory Viruses, National Institute of Infectious Diseases, Japan Institute for Health Security, Japan.
Abstract:
In Japan, nationwide surveillance of acute respiratory infections (ARI) was launched in April 2025, enabling monitoring of multiple respiratory pathogens. Human parainfluenza virus type 3 (HPIV3) is an important cause of respiratory infections. In 2025, HPIV3 increased from spring to summer, and Japanese media raised concerns about the emergence of a novel pathogen because public surveillance data on HPIV3 trends had not previously been available. In this study, phylogenetic analysis of HPIV3 isolates obtained in eastern Japan in 2025 was performed using nearly complete genome sequences. The isolates were grouped within previously circulating clusters (C1 and C2), and several sequences were closely related to viruses detected in Fukushima between 2018 and 2024, suggesting continued circulation of HPIV3 within the same geographic region (Fukushima Prefecture and surrounding areas), although broader circulation cannot be excluded. Some sequences were related to strains reported outside Japan, suggesting possible introduction from abroad. Overall, the sequences were highly similar and no distinct lineage forming a new cluster was observed. These findings indicate that the HPIV3 strains detected in 2025 belong to previously circulating lineages and do not represent the emergence of a new lineage.
Insights
In 2025, human parainfluenza virus type 3 (HPIV3) surveillance in Japan showed increased circulation. Phylogenetic analysis confirmed these HPIV3 strains belong to previously circulating lineages, not a novel pathogen.
Area of Science:
- Virology
- Epidemiology
- Genomics
Background:
- Nationwide surveillance for acute respiratory infections (ARI) began in Japan in April 2025.
- Human parainfluenza virus type 3 (HPIV3) is a significant respiratory pathogen.
- Public concern arose in 2025 regarding a potential novel pathogen due to increased HPIV3 activity and lack of prior trend data.
Purpose of the Study:
- To investigate the genetic characteristics of HPIV3 strains circulating in Japan in 2025.
- To determine if the observed HPIV3 increase represented a new lineage or previously circulating strains.
Main Methods:
- Phylogenetic analysis of nearly complete genome sequences from HPIV3 isolates in eastern Japan.
- Comparison of 2025 isolates with historical data and international strains.
Main Results:
- HPIV3 isolates from 2025 clustered within previously identified lineages (C1 and C2).
- Sequences showed close relationships to viruses detected in Fukushima (2018-2024), suggesting regional persistence.
- Some strains exhibited similarities to international isolates, indicating potential importations.
- No distinct new lineage or novel cluster was identified.
Conclusions:
- The HPIV3 strains detected in Japan in 2025 are not novel but belong to established circulating lineages.
- The findings alleviate concerns about a new pathogen emerging, attributing the increase to known HPIV3 strains.
More Related Videos
Related Concept Videos
Influenza
Viral Recombination
Infectious Diseases and Their Occurrence
Respiratory Syncytial Virus Disease
Arboviral Encephalitis
Human Virome


